Company Overview and News

4
An evening walk down Dalal Street | Bears have it their way! Sensex tanks 500 points, Nifty gives up 11,400 amid weak rupee

2018-09-17 moneycontrol
A sea of red took over D-Street on Monday as selloff in majority of sectors ensured that complete control was handed over to the bears. The Nifty managed to give up 11,400, while the Sensex tanked over 500 points lower.
BAJAJHIND DB 532707 532955 BAJFINANCE DYNPRO BJJQY 500570 RECLTD 500032 TATAMOTORS 500034 TTM

 
Sugar stocks maintain upward momentum; up 20% post hike in ethanol price

2018-09-17 moneycontrol
Sugar stocks continued their upward momentum on Monday after Cabinet approved hike in ethanol price by up to 25 percent in the last week.
BAJAJHIND 500032

 
Bajaj Group plans ₹ 3,000 crore IPO of power generation business

2018-08-20 livemint
Mumbai: Bajaj Group plans to raise about ₹ 3,000 crore through an initial public offering (IPO) of its power generation business, said two people aware of the plans. The company is expected to soon file a draft prospectus with capital markets regulator Securities and Exchange Board of India (Sebi) for a share sale, the people said. “They have been working on the IPO of the power business over the past few months,” said one of the two people, requesting anonymity as he is not authorized to speak to reporters.
BAJAJHIND U96 IIFL 532636 500032 SCRPF SCRPY

 
Bajaj Hindusthan Sugar Limited - Shareholders meeting

2018-08-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BAJAJHIND 500032

 
Bajaj Hindusthan to sell Lalitpur Power stake

2018-07-12 freepressjournal.in
New Delhi : Bajaj Hindusthan Sugar plans to sell its entire 17.51 per cent stake in the group firm Lalitpur Power Generation Company (LPGCL), estimated to be worth Rs 1,100 crore.
BAJAJHIND 500032

 
Bajaj Hindusthan to sell 17.51% stake in group#39;s power firm LPGCL

2018-07-11 moneycontrol
Bajaj Hindusthan Sugar plans to sell its entire 17.51 percent stake in the group firm Lalitpur Power Generation Company Ltd (LPGCL), estimated to be worth Rs 1,100 crore. The company had invested Rs 770 crore in LPGCL and now needs to divest non-core assets as per the debt restructuring scheme approved by the lenders.
BAJAJHIND 500032

 
Bajaj Hindusthan Sugar Limited - Clarification

2018-07-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BAJAJHIND 500032

 
Bajaj Hindusthan Sugar board okays share sale in Lalitpur Power

2018-07-06 thehindubusinessline
The board of directors of Bajaj Hindusthan Sugar on Friday approved a proposal for convening an Extraordinary General Meeting to consider ordinary and special resolutions for sale and transfer of 1,54,39,900 equity shares of ₹10 each held by the company in Lalitpur Power Generation Company to Bajaj Energy, a related party of the company. Shares of Bajaj Hindusthan ended flat at ₹6.50 on the NSE.
BAJAJHIND 500032

 
Bajaj Hindusthan Sugar Limited - Outcome of Board Meeting

2018-07-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BAJAJHIND 500032

2
Sugar stocks ‘sweeten’ on govt bailout package

2018-06-06 thehindubusinessline
Shares of sugar producers climbed in the afternoon trade as the Union Cabinet has approved a Rs 8,500-crore bailout package for the sugar industry which includes Rs 4,500-crore soft loan for building ethanol production capacity and creating a 3-million-tonne stockpile to soak up excess supply.
BAJAJHIND 530363 UGARSUGAR NDAQ IDFCBANK DCMSHRIRAM 500032 523367 539437

 
Sugar stocks ‘sweeten’ on reports of bailout package

2018-06-05 thehindubusinessline
Sugar stocks rose up to 7 per cent today amid reports that the government is likely to announce a bailout package of over Rs 7,000 crore to ensure cash-starved mills clear dues to farmers at the earliest.
BAJAJHIND MAWANASUG BALRAMCHIN 523371 UTTAMSUGAR 532729 500119 500038 500032 DHAMPURSUG

 
Fire at Bajaj Hindusthan's Kinauni sugar mill

2018-05-28 thehindubusinessline
In another incident of fire, sugar major Bajaj Hindusthan Sugar has said that in the afternoon of Saturday, May 26, a fire broke out in one of the storage tanks of the company’s distillery division at Kinauni, Meerut, Uttar Pradesh, during loading of ethanol in containers.
BAJAJHIND 500032

 
Bajaj Hindusthan Sugar Limited - Updates

2018-05-28 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BAJAJHIND 500032

 
Bajaj Hindusthan Sugar posts Q4 loss at Rs158 crore

2018-05-27 livemint
New Delhi: Bajaj Hindusthan Sugar on Saturday reported a net loss of Rs157.77 crore in the March quarter of 2017-18. In the January-March period of the preceding financial year, its had a net profit of Rs 259.13 crore.
BAJAJHIND 500032

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

10h - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

10h - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

12h - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...